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Introduction: Phytotherapy is increasingly evident in the complex treatment o f  diseases due 
to the elucidation o f  the active compounds from plants with beneficial pharmacological effects. The 
creation o f  a scientific base on rational use o f  medicinal herbs opens new prospects for the 
pharmacotherapy improving. Therefore, the issue o f  interactions between drugs and plant drugs in 
terms o f  synergism and antagonism becomes current for arguing security and safety o f  their 
association. Data on such interactions are minor and dispersed, as they are more difficult due to the 
varied and rich content o f  active ingredients from plants. Interactions between herbs and drugs can 
be detected in pharmacotherapeutic and toxicological aspect.
Purpose and objectives: is the bibliographic study o f  the pharmacodynamic interactions 
between medical herbs and drugs, their reflection in the training process.
The results and discussion: Pharmacodynamic studies o f  herbal drugs and o f  their active 
principles have demonstrated the presence o f  a variety o f  pharmacological effects (anti-inflammatory, 
immunostimulant, antioxidant, antimicrobial, sedative, anxiolytic, antispasmodic, etc.). It was 
determined that the association with drugs can have unpredictable consequences, both therapeutic and 
toxicologic. Thus, pharmacodynamic interactions can be achieved by: drug interaction with receptors, 
allosteric modulation o f  receptor sites; influencing mediator systems (release, uptake, synthesis, 
metabolism), modifying the activity o f  enzymes, changing the activity o f  organs and systems, the 
development o f  liver, kidney disturbances etc. Thus, St. John's wort drugs manifest antidepressant 
action by inhibiting the norepinephrine, serotonin, dopamine reuptake. However, they also induce 
adverse effects in combination with antidepressants as selective inhibitor o f  the reuptake o f  these 
neurotransmitters. Valerian benzodiazepines shows the same effect by modulating the GABA - ergic 
system. Echinacea, ginseng, by their phenolic triterpenes, flavonoids, saponins, polysaccharides 
determine the immunomodulatory effect which can produce contradictory effects in patients under 
immunosuppressive organ transplantation. Garlic drugs develop multiple metabolic effects, including 
the inhibition o f  lipid-lowering hydroxy-methyl-glutaryl - CoA - reductase for stimulation o f  the 
efficiency o f  statins. The associated use o f  these compounds may increase the incidence o f 
rhabdo myolysis due to increased concentration o f  statins as a result o f  pharmacokinetic interactions. It is 
necessary to mention that the result o f  pharmacokinetic interactions, particularly produced by the 
induction and/or inhibition o f  cytochrome P-450 and transport systems will be characterized by the 
amplification and/or decrease o f  the pharmacological effects and adverse reactions.
Conclusion. The associated use o f  drugs with medicinal herbs for the treatment o f diseases requires 
strict monitoring o f  the efficiency and safety through the possible pharmacokinetic and pharmacodynamic 
interactions. The information about the consequences o f  these interactions must be brought to the attention 
o f  physicians, pharmacists and patients in order to ensure a rational pharmacotherapy.
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Introduction: The utilization on a large scale from 30 to 85% o f  basic and active compounds from 
plants according to WHO data is an actual problem o f  modem medicine due to the possible interactions 
with drugs. International bodies (WHO, FDA, EMEA, EFSA) are much concerned about the spreading of 
medical herbs marketing which do not contain a proper reference material and/or not being certified by the
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